Demant A/S : Strong performance to continue
>Solid finish of 2021 - Demant’s FY 2021 revenues of DKK 18,418m (+27.3% y-o-y) were driven by organic growth of 27% on the back of a strong performance at hearing aids and hearing care with 34% organic growth, respectively. The acoustic capabilities of the Oticon More hearing aid platform pushed forward the wholesale business and pent-up demand following the coronavirus pandemic. In addition, the acoustic retail activities profited also from the hearing healthcare re...William Demant Holding is a holding company. Through its subsidiaries, Co develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. Co. focuses on four areas: Hearing Devices, Diagnostic Instruments, Hearing Implants and Personal Communication. Co.'s hearing devices include Oticon, Bernafon, Sonic, Phonic Ear, and FrontRow. Co.'s Hearing implant consist of Oticon Medical. Co.'s diagnostic instruments include Maico, Interacoustics, Amplivox, Grason-Stadler, MedRx, and Micromedical. Co.'s personal communication consists of Sennheiser Communications.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.